4//SEC Filing
Baumal Caroline 4
Accession 0001492422-26-000016
CIK 0001492422other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:06 PM ET
Size
4.7 KB
Accession
0001492422-26-000016
Insider Transaction Report
Form 4
Baumal Caroline
Chief Medical Officer
Transactions
- Sale
Common Stock
2026-01-05$25.53/sh−3,020$77,097→ 91,206 total
Footnotes (2)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 3, 2026.
- [F2]This includes 925 shares from October 31, 2025 ESPP purchase.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001961100
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:06 PM ET
- Size
- 4.7 KB